Northwestern Mutual Wealth Management
IRD

Northwestern Mutual Wealth Management’s Opus Genetics IRD Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10
Closed -$12 – 3996
2024
Q4 		$12 Buy
+10
New +$11 ﹤0.01% 3558
2018
Q2 		– Sell
-2
Closed – – 2512
2018
Q1 		$0 Buy
+2
New +$182 ﹤0.01% 2453
2016
Q1 		– Sell
-2
Closed – – 2314
2015
Q4 		$0 Buy
+2
New +$425 ﹤0.01% 1880
2013
Q3 		– Hold
0
– – – 1490
2013
Q2 		– Hold
0
– – – 1255

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's IRD Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Opus Genetics (IRD) in Q1 2025, closing a stake of 10 shares — an estimated $12 sold.

Northwestern Mutual Wealth Management first reported a position in IRD in Q4 2015 and held it in 3 quarters. The position peaked at $12 in Q4 2024. 46 funds tracked by Wall St. Rank hold IRD as of Q1 2025.

  • Northwestern Mutual Wealth Management reported no remaining Opus Genetics position as of Q1 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 10 Opus Genetics shares in Q1 2025, an estimated $12.
  • Northwestern Mutual Wealth Management first reported a position in Opus Genetics in Q4 2015 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Opus Genetics position peaked at $12 in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.